Table 5 Comparisons of outcomes between matched groups of no corticosteroid and low-dose corticosteroid
From: Adjunctive corticosteroid therapy for inpatients with Mycoplasma pneumoniae pneumonia
Characteristic | No corticosteroid | Low-dose corticosteroids | Â | ||
|---|---|---|---|---|---|
n = 251 | n = 251 | p value | |||
30-day mortality | 5 | (2.0) | 5 | (2.0) | 1.0000 |
In-hospital hyperglycemia requiring insulin treatment | 20 | (8.0) | 30 | (12.0) | 0.1794 |
Length of stay, days | 12.8 | ±9.1 | 17.6 | ±18.0 | 0.0055 |
Length of anitmicrobial treatment, days | 7.1 | ±5.1 | 8.9 | ±6.7 | 0.0026 |
Total cost of all drugs in hospitalization | |||||
 Japanese Yen ± SD | 63,265 | ±142,385 | 103,566 | ±237,757 | < 0.0001 |
 Euro ± SD | 543 | ±1223 | 889 | ±2042 |  |
 US Dollar ± SD | 625 | ±1406 | 1023 | ±2348 |  |